Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
CME-accredited Webinar: The Use of Angiotensin II in Vasodilatory Shock
February 2024
A CME-accredited webinar covers vasodilatory shock, the current vasoactive agents, and acritical evaluation of emerging therapies.
Read more
21st February 2024
CME-accredited Webinar: The Use of Angiotensin II in Vasodilatory Shock
A CME-accredited webinar covers vasodilatory shock, the current vasoactive agents, and acritical evaluation of emerging therapies.
13th December 2023
Autologous Transplant or Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Large B-cell Lymphoma: How to Choose?
Expert Madiha Iqbal, Consultant and Assistant Professor of Medicine, Mayo Clinic, Jacksonville, Florida, USA, presents on the treatment…
11th July 2023
What to do when CAR Ts are not the most appropriate option in 2L DLBCL: Current treatment options for transplant-ineligible patients
An innovative session highlighting patient-focused decision-making and a dynamic debate on current 2L DLBCL treatment options.
20th March 2023
Updates on CAR-NK Cells
This presentation offers insight into chimeric antigen receptor-transduced (CAR) natural killer (NK) cells, providing an update on the involvement of these cells in a host of topics, from stem cell transplantation to cancer.
27th February 2023
Update on AL Amyloidosis
This webinar discusses the critical factors involved in amyloidosis diagnosis, prognosis and management, describing both haematologic and organ responses to treatment. The presentation also delves into the origins of cardiac amyloidosis, outlining investigations required to assess organ involvement and establish a diagnosis.
28th November 2022
DOACs in Review - How did we get here?
This upcoming webinar discussion shares clinical insights from an expert in the use of direct oral anticoagulants for the treatment of…
20th August 2022
Increasing Awareness in Beta-Thalassemia
This series of webinars focusses on Beta-Thalassemia. These are scientific presentations and discussions for the purpose of scientific exchange.
16th August 2022
Is Complete Response Enough? An Expert Look Towards the Future of Higher-Risk MDS Treatment
This satellite symposium discusses current key topics in higher-risk MDS, including treatment outcome measures
Loading posts...
1
2
Next »